Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present... | May 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.36 and traded as high as $8.71. Alpine Immune Sciences shares last traded at $8.57, with a volume of 181,061 shares. Analyst Ratings Changes Several brokerages […]
BELLEVUE, Wash., May 17, 2023 (GLOBE NEWSWIRE) -- Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion...
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results... | May 11, 2023